ELIQUIS
Live / Registered — Registered and renewed (as of 18 Apr 2024)
What this means for you
Registered since 17 Dec 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Dec 2023).
Record
- Serial number
- 85544142
- Registration number
- 4451882
- Mark type
- Design + words
- Filed
- 16 Feb 2012
- Published for opposition
- 22 Jan 2013
- Registered
- 17 Dec 2013
- Next maintenance due
- 17 Dec 2023
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of cardiovascular diseases and disorders
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prior registrations
Prosecution history
- 18 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Apr 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Dec 2023 — TEAS SECTION 8 & 9 RECEIVED
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Dec 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Jan 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Jan 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Jan 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Dec 2018 — TEAS SECTION 8 & 15 RECEIVED